Amgen Bioprocessing Center News
December 1, 2014
Dr. Parviz Shamlou, Director of Amgen Bioprocessing Center, and KiriLynn Svay, Director of Bioprocess Engineering Operations, talk about the history of bioprocessing, its importance to industry and their plans for ABC moving forward.
October 23, 2014
Dr. Parviz Shamlou, new director of the Amgen Bioprocessing Center, talks about his 40-year journey across three continents and two 'worlds'-and, of course, about his plans for ABC moving forward.
September 8, 2014
Thirty members of the founding class of the Minerva Schools at KGI - from 14 countries and territories - began classes this week in San Francisco.
November 13, 2013
KGI has joined forces with Biocon, India's largest biotech company, to create the 'Biocon KGI certificate in Biosciences.' The 16-week program, which will begin in January of 2014, expands KGI's current bioscience management certificate concept to Bangalore.
May 22, 2013
Dr. Matt Croughan has accepted the position of chief technology officer at Sapphire Energy, Inc., one of the world leaders in algae-based Green Crude oil production.
March 16, 2011
Professor Matthew Croughan, PhD, will give the keynote address at the Northern California chapter of the American Institute of Chemical Engineers' (AICHE) 49th Annual Symposium on April 14, 2011, in Berkeley, California.
January 21, 2011
Students will make valuable connections with industry leaders and learn about new developments in bioprocessing education during KGI's next Focus Track Friday event on Feb. 4, featuring experts from the Amgen Bioprocessing Center Advisory Board (ABCAB).
October 14, 2010
Professor Matthew Croughan, PhD, will give a presentation at IBC Life Sciences’ 6th Biopharmaceutical Manufacturing and Development (BMD) Summit being held November 1-3 in Boston, Massachusetts.
June 14, 2010
Professor Matthew Croughan, PhD, will deliver a keynote presentation at IBC Life Sciences’ 6th Annual Cell Line Development and Engineering Summit, being held June 21-23 in San Francisco. The program attracts thought leaders from business and academia to collectively examine and provide solutions to industry’s challenges.
April 9, 2008
Dr. Matthew Croughan, KGI’s George B. and Joy Rathmann professor and director of the Amgen Bioprocessing Center, will present a keynote talk on 25 years of Chinese hamster ovary (CHO) cell culture achievements.
January 17, 2008
CLAREMONT, Calif., Jan. 18, 2008 – Keck Graduate Institute (KGI) today announced that Dr. Matthew Croughan, KGI’s George B. and Joy Rathmann professor and director of the Amgen Bioprocessing Center, will discuss 25 years of key achievements and technical challenges regarding Chinese hamster ovary (CHO) cell culture at the Society for Biological Engineering’s First International Conference on Stem Cell Engineering on Wednesday, January, 23, 2008, in Coronado, Calif.
December 6, 2007
CLAREMONT, Calif., Dec. 7, 2007 – Keck Graduate Institute (KGI) today announced that Dr. Matthew Croughan, KGI’s George B. and Joy Rathmann professor and director of the Amgen Bioprocessing Center, has been elected to the American Institute for Medical and Biological Engineering’s (AIMBE) College of Fellows.
March 22, 2007
Keck Graduate Institute (KGI) announced today that The Ralph M. Parsons Foundation has awarded $200,000 to KGI for expansion of its Amgen Bioprocessing Center, a critical educational laboratory for teaching tomorrow’s leaders of the biopharmaceutical industry.
February 1, 2007
Keck Graduate Institute (KGI) announced today the establishment of a new lecture series showcasing some of the top business and scientific leaders in bioprocessing.
January 31, 2006
After an extensive nation-wide search, Keck Graduate Institute (KGI) is pleased to announce that Dr. Matthew S. Croughan has been named the first George B. and Joy Rathmann Professor and Director of the Amgen Bioprocessing Center.
October 3, 2005
George Rathmann's life has embodied the spirit of KGI - an institution dedicated to bioscience education and research that benefits society.
April 15, 2005
The new facility will be used to educate students about the commercial development and production of potentially life-saving biological molecules.